These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24519662)

  • 1. [Upstream therapy for atrial fibrillation].
    Goette A; Hammwöhner M; Bukowska A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):33-40. PubMed ID: 24519662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological remodeling in atrial fibrillation].
    Goette A; Lendeckel U
    Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.
    Savelieva I; Camm J
    Europace; 2008 Jun; 10(6):647-65. PubMed ID: 18515286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dronedarone: the new antiarrythmic agent?].
    Brachmann J; Sinha AM
    Herzschrittmacherther Elektrophysiol; 2009 Jun; 20(2):73-5. PubMed ID: 19517208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream therapy for atrial fibrillation.
    Kumagai K
    Circ J; 2007; 71 Suppl A():A75-81. PubMed ID: 17587744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].
    Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].
    Hammwöhner M; D'Alessandro A; Dobrev D; Kirchhof P; Goette A
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):73-80. PubMed ID: 16786465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs for atrial fibrillation.
    Hammwöhner M; Smid J; Lendeckel U; Goette A
    J Interv Card Electrophysiol; 2008 Oct; 23(1):15-21. PubMed ID: 18535890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
    Burashnikov A
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):492-505. PubMed ID: 33165131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of unilateral temporary stellate ganglion block on human atrial electrophysiological properties and atrial fibrillation inducibility.
    Leftheriotis D; Flevari P; Kossyvakis C; Katsaras D; Batistaki C; Arvaniti C; Giannopoulos G; Deftereos S; Kostopanagiotou G; Lekakis J
    Heart Rhythm; 2016 Nov; 13(11):2111-2117. PubMed ID: 27353237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
    Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
    Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstream therapy for atrial fibrillation in heart failure.
    Goette A
    Heart Fail Clin; 2013 Oct; 9(4):417-25, viii. PubMed ID: 24054475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
    Neumann T; Hölschermann H
    Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
    [No Abstract]   [Full Text] [Related]  

  • 16. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of amiodarone on electrophysiologic properties of pulmonary veins in patients with paroxysmal atrial fibrillation.
    Rostock T; Servatius H; Risius T; Ventura R; Weiss C; Meinertz T; Willems S
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):39-44. PubMed ID: 15673385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.
    Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive insight of novel antioxidant therapies for atrial fibrillation management.
    Orenes-Piñero E; Valdés M; Lip GY; Marín F
    Drug Metab Rev; 2015 Aug; 47(3):388-400. PubMed ID: 27412960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.